Herpes Zoster
📧 Sign up to get email alerts when something new happens for Herpes Zoster.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED) [Phase 1]
A Phase 1 trial completed evaluating safety and antibody response of V212 in healthy adults for herpes zoster.
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older [Phase 3]
A Phase 3 trial assessing long-term immunogenicity and safety of GSK's herpes zoster subunit vaccine with re-vaccination at 10 years; result…
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Enhancing a Sustainable Pharmacy-based Immunization Program in Two States [NA]
Completed clinical trial assessing a sustainable pharmacy-based immunization program in two states; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster [Phase 3]
Phase 3 trial comparing oral famciclovir to aciclovir in patients with herpes zoster has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002) [Phase 1]
Phase 1 study of an investigational heat-treated V212 varicella-zoster vaccine in immunocompromised adults has completed with results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013) [Phase 1]
Phase 1 study evaluating safety and immunogenicity of an inactivated varicella-zoster vaccine in adults with hematologic malignancies receiv…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates [NA]
A completed clinical trial evaluated the use of an electronic medical record in primary care to improve herpes zoster vaccination rates, wit…
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009) [Phase 2]
Phase 2 clinical trial assessing safety and immunogenicity of an inactivated Varicella Zoster Virus vaccine in adults with autoimmune diseas…
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects [Phase 2]
Phase 2 trial assessing safety and immunogenicity of the zoster vaccine GSK1437173A in elderly subjects has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Month 30 & 42 Extension Studies of CRD-004 Primary Study [Phase 2]
Extension studies for CRD-004 in herpes zoster completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-23Clinical Trial Update: Dose-finding Study of ASP2151 in Subjects With Herpes Zoster [Phase 2]
Phase 2 dose-finding study of ASP2151 in subjects with herpes zoster has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: Phase III Study of ASP2151 in Herpes Zoster Patients [Phase 3]
Phase III study of ASP2151 in herpes zoster has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age [Phase 3]
Phase 3 trial evaluating the impact of reactogenicity on quality of life after administration of GSK's HZ/su vaccine (GSK1437173A) in adults…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy [Phase 3]
Phase 3 trial update on immunogenicity and safety of GSK's Herpes Zoster vaccine in adults with solid tumors receiving chemotherapy; study c…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Acupuncture in Herpes Zoster Neuralgia (ACUZoster) [Phase 4]
Phase 4 clinical trial update assessing acupuncture for herpes zoster neuralgia and postherpetic neuralgia has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant [Phase 3]
Phase 3 trial assessing immunogenicity and safety of GSK's HZ/su vaccine in adults 18+ with renal transplant; completed with results posted …
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001) [Phase 3]
Phase 3 trial evaluating an inactivated varicella-zoster vaccine for prevention of herpes zoster and related complications in hematopoietic …
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Herpes Zoster Vaccine for Bone Marrow Transplant Donors [Phase 2]
Phase 2 clinical trial evaluating a herpes zoster vaccine for bone marrow donor vaccination has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN). [Phase 2]
Phase 2 trial update reports effectiveness and safety findings for carisbamate (RWJ-333369) in postherpetic neuralgia, with the study comple…
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of GlaxoSmithKline's herpes zoster subunit vaccine (Shingrix) when co-administered wi…
-
CLINICAL_TRIALS trial_result · 2018-04-13Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011) [Phase 3]
Phase 3 trial evaluating the safety and efficacy of the inactivated varicella-zoster vaccine for preventing herpes zoster and related compli…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors [Phase 4]
Phase 4 trial evaluating ZOSTAVAX in patients about to start chemotherapy for solid organ tumors; results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-04-04Clinical Trial Update: Scrambler Therapy in Treating Chronic Pain in Patients With Rash From Varicella Zoster Virus Infection [NA]
A completed Mayo Clinic-sponsored trial evaluating scrambler therapy for chronic pain in patients with a rash due to Varicella Zoster virus …
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults [Phase 1]
Phase 1 trial update showing safety and immunogenicity of GlaxoSmithKline's Herpes Zoster Vaccine 1437173A in healthy ethnic Japanese adults…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A [Phase 3]
Phase 3 trial update for GSK's herpes zoster vaccine GSK1437173A shows completed status with results posted.